SPG302 / Spinogenix 
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SPG302 / Spinogenix
SPG302-ALZ-101, NCT06427668: Study of SPG302 in Adult Participants With Mild-to-Moderate Alzheimer's Disease (AD)

Recruiting
2
24
RoW
SPG302, Placebo
Spinogenix
Alzheimer Disease
12/25
06/26
SPG302-SCZ-201, NCT06442462: Study of SPG302 in Adults With Schizophrenia

Recruiting
2
32
RoW
SPG302, Placebo
Spinogenix
Schizophrenia
06/25
10/25
NCT05882695: Study of SPG302 in Healthy Volunteers and ALS Participants

Active, not recruiting
1
112
RoW
SPG302, Placebo
Spinogenix, Novotech (Australia) Pty Limited
Amyotrophic Lateral Sclerosis
05/25
12/25

Download Options